Aradigm Reports on Study Results For Non-CF Bronchiectasis Therapy Liposomal Ciprofloxacin
News
A team of investigators from Oregon State University, Corvallis (OSU) and Aradigm Corporation, an emerging specialty pharmaceutical company focused on the development and commercialization of drugs for the prevention and ... Read more